Sphingosine kinase-1 is overexpressed and correlates with hypoxia in osteosarcoma: relationship with clinicopathological parameters - Archive ouverte HAL Access content directly
Journal Articles Cancers Year : 2022

Sphingosine kinase-1 is overexpressed and correlates with hypoxia in osteosarcoma: relationship with clinicopathological parameters

, , , , , , , , , , , , , , , (1) , ,
1
Anne Gomez-Brouchet
  • Function : Author
Claire Illac
  • Function : Author
Adeline Ledoux
  • Function : Author
Pierre-Yves Fortin
  • Function : Author
Sandra de Barros
  • Function : Author
Clémentine Vabre
  • Function : Author
Fabien Despas
  • Function : Author
Corinne Bouvier
  • Function : Author
Sébastien Aubert
  • Function : Author
  • PersonId : 865845
Gonzague de Pinieux
  • Function : Author
Fréderique Larousserie
  • Function : Author
Louise Galmiche
  • Function : Author
Franck Talmont
Stuart Pitson
Marie-Lise Maddelein
  • Function : Author
Sophie Peries
  • Function : Author
Christelle Casaroli
  • Function : Author

Abstract

The Sphingosine kinase-1/Sphingosine 1-Phosphate (SphK1/S1P) signaling pathway is overexpressed in various cancers, and is instrumental for the adaptation to hypoxia in a number of solid tumor models, but no data are available in osteosarcoma. Here we report that SphK1 and the S1P1 receptor are involved in HIF-1α accumulation in hypoxic osteosarcoma cells. FTY720 (Fingolimod), which targets SphK1 and S1P1, prevented HIF-1α accumulation, and also inhibited cell proliferation in both normoxia and hypoxia unlike conventional chemotherapy. In human biopsies, a significant increase of SphK1 activity was observed in cancer compared with normal bones. In all sets of TMA samples (130 cases of osteosarcoma), immunohistochemical analysis showed the hypoxic marker GLUT-1, SphK1 and S1P1 were expressed in tumors. SphK1 correlated with the GLUT-1 suggesting that SphK1 is overexpressed and correlates with intratumoral hypoxia. No correlation was found between GLUT-1 or SphK1 and response to chemotherapy, but a statistical difference was found with increased S1P1 expression in patients with poor response in long bone osteosarcomas. Importantly, multivariate analyses showed that GLUT-1 was associated with an increased risk of death in flat bone, whereas SphK1 and S1P1 were associated with an increased risk of death in long bones.
Fichier principal
Vignette du fichier
cancers-14-00499-v2.pdf (1.83 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

hal-03312272 , version 1 (02-08-2021)
hal-03312272 , version 2 (09-02-2022)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Anne Gomez-Brouchet, Claire Illac, Adeline Ledoux, Pierre-Yves Fortin, Sandra de Barros, et al.. Sphingosine kinase-1 is overexpressed and correlates with hypoxia in osteosarcoma: relationship with clinicopathological parameters. Cancers, 2022, 14 (3), pp.499. ⟨10.3390/cancers14030499⟩. ⟨hal-03312272v2⟩
117 View
41 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More